Hepatopancreatic Microsporidiosis (HPM) caused by ‘Enterocytozoon hepatopenaei (EHP) is a severe disease causing growth retardation and economic loss to the shrimp farmers. The annual economic loss due to EHP in Indian shrimp farms was estimated to be around Rs 4000 crores. ICAR-CIBA has developed a cure for EHP named ‘CIBA EHP cura- I’ after 5 years of exclusive research on EHP therapeutics. ‘CIBA EHP cura- I’ significantly controls the proliferation of EHP, reduces bacterial load and significantly improves the immunity, health, and growth of shrimp.
ICAR-CIBA signed a Memorandum of Understanding (MoU) with Sai Aqua Feeds, Guntur, Andhra Pradesh on 6th September 2023 for a collaborative research for field validation of CIBA EHP Cura I’- technology.
During the occasion, Dr. Kuldeep K.Lal, Director, ICAR-CIBA highlighted the severity of EHP pathogen in shrimp aquaculture and the significance of CIBA EHP cura I in the field.
Dr T. Sathish kumar, Scientist and principal investigator of CIBA EHP cura I, briefed about the importance of this product and informed the association with Sai aqua feeds in initial field trials.
Mr Vijay Marutha Varma, M/s. Sai Aqua Feeds, Guntur, Andhra Pradesh highlighted their association with ICAR-CIBA and conveyed their overwhelming satisfaction with ‘CIBA EHP cura I’ performance in EHP cure and expressed their willingness to sign the MoU.
The event was organized by the Institute Technology Management Unit (ITMU) CIBA, and Dr. P.K. Patil, Principal scientist expressed the vote of thanks.